A [3+2] Annulation Route to Annonaceous Acetogenins

A [3 2] 成环途径为番荔枝苷

基本信息

  • 批准号:
    6772418
  • 负责人:
  • 金额:
    $ 4.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2005-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many compounds from the annonaceous acetogenin class of natural products exhibit highly potent and selective cytotoxicities against several types of human tumor cells. Members of this class bearing central bistetrahydrofuran cores are of particular interest as anti-cancer drugs. One obstacle towards this goal is the lack of precise information regarding the mechanism of the natural products' biological activity. To facilitate understanding the role these compounds have in promoting tumor death, there is a need for efficient and stereochemically general synthetic routes towards the annonaceous acetogenins. The proposed research will develop total syntheses of three members of the annonaceous acetogenin family: 10-hydroxytrilobacin, bullatacin, and rollimembrin. These three bis-tetrahydrofuran containing compounds all have cytotoxic or anti-tumor properties, and the total syntheses of two are currently unknown. A key [3+2] annulation reaction of chiral allylsilanes will be employed to construct the bis-tetrahydrofuran fragment of each natural product in a stereocontrolled fashion. Completion of the proposed total syntheses will demonstrate the stereochemical and functional diversity that the [3+2] annulation approach provides in the construction of annonaceous acetogenins and their analogs.
描述(由申请人提供):番荔枝内酯类天然产物的许多化合物对几种类型的人肿瘤细胞表现出高度有效和选择性的细胞毒性。具有中心双四氢呋喃核的这类成员作为抗癌药物特别令人感兴趣。实现这一目标的一个障碍是缺乏关于天然产品生物活性机制的准确信息。为了便于理解这些化合物在促进肿瘤死亡中的作用,需要针对番荔枝内酯的有效的和立体化学上通用的合成路线。该研究将开发番荔枝内酯家族的三个成员:10-hydroxytrilobacin,bullatacin和rolimemetrin的全合成。这三种含双四氢呋喃的化合物都具有细胞毒性或抗肿瘤性质,其中两种化合物的全合成方法目前尚不清楚。一个关键的[3+2]成环反应的手性烯丙基硅烷将被用来构建双-四氢呋喃片段的每一个天然产物的立体控制的方式。完成所提出的全合成将证明[3+2]成环方法在番荔枝内酯及其类似物的构建中提供的立体化学和功能多样性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC MERTZ其他文献

ERIC MERTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC MERTZ', 18)}}的其他基金

A [3+2] Annulation Route to Annonaceous Acetogenins
A [3 2] 成环途径为番荔枝苷
  • 批准号:
    6694174
  • 财政年份:
    2003
  • 资助金额:
    $ 4.3万
  • 项目类别:

相似海外基金

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10448926
  • 财政年份:
    2021
  • 资助金额:
    $ 4.3万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10491861
  • 财政年份:
    2021
  • 资助金额:
    $ 4.3万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10675535
  • 财政年份:
    2021
  • 资助金额:
    $ 4.3万
  • 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
  • 批准号:
    EP/S021868/1
  • 财政年份:
    2019
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
  • 批准号:
    529840-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403724
  • 财政年份:
    2014
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403697
  • 财政年份:
    2014
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
  • 批准号:
    131690
  • 财政年份:
    2014
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
  • 批准号:
    131338
  • 财政年份:
    2013
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
  • 批准号:
    429734-2011
  • 财政年份:
    2012
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了